<VariationArchive RecordType="classified" VariationID="537740" VariationName="NC_000023.11:g.(?_139530759)_(139562076_?)del" VariationType="Deletion" Accession="VCV000537740" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="534874" VariationID="537740">
      <GeneList>
        <Gene Symbol="F9" FullName="coagulation factor IX" GeneID="2158" HGNC_ID="HGNC:3551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq27.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="139530739" stop="139563459" display_start="139530739" display_stop="139563459" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="138612894" stop="138645616" display_start="138612894" display_stop="138645616" Strand="+" />
          </Location>
          <OMIM>300746</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F9">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F9">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_139530759)_(139562076_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq27.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" innerStart="139530759" innerStop="139562076" display_start="139530759" display_stop="139562076" variantLength="31318" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="138612918" innerStop="138644235" display_start="138612918" display_stop="138644235" variantLength="31318" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_138612918)_(138644235_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_138612918)_(138644235_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(?_139530759)_(139562076_?)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(?_139530759)_(139562076_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_139530759)_(139562076_?)del AND multiple conditions" Accession="RCV000646762" Version="1">
        <ClassifiedConditionList TraitSetID="26555">
          <ClassifiedCondition DB="MedGen" ID="C0008533">Hereditary factor IX deficiency disease</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2749016">Thrombophilia, X-linked, due to factor 9 defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2198809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24375831</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3029178</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4045960</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8304338</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26555" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6860" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Thrombophilia, X-linked, due to factor 9 defect</ElementValue>
                <XRef ID="MONDO:0010432" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombophilia, X-linked, due to factor IX defect</ElementValue>
                <XRef ID="THROMBOPHILIA%2C+X-LINKED%2C+DUE+TO+FACTOR+IX+DEFECT/9399" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THPH8</ElementValue>
                <XRef Type="MIM" ID="300807" DB="OMIM" />
              </Symbol>
              <XRef ID="C2749016" DB="MedGen" />
              <XRef ID="MONDO:0010432" DB="MONDO" />
              <XRef Type="MIM" ID="300807" DB="OMIM" />
            </Trait>
            <Trait ID="2027" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">F9 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="306900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLASMA THROMBOPLASTIN COMPONENT DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="306900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia B</ElementValue>
                <XRef ID="MONDO:0010604" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Christmas disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor IX deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEM B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary factor IX deficiency disease</ElementValue>
                <XRef ID="Hemophilia+B/3315" DB="Genetic Alliance" />
                <XRef ID="41788008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HEMB</ElementValue>
                <XRef Type="MIM" ID="306900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8732" />
                <XRef ID="8732" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hemophilia B is characterized by deficiency in factor IX clotting activity that results in prolonged oozing after injuries, tooth extractions, or surgery, and delayed or recurrent bleeding prior to complete wound healing. The age of diagnosis and frequency of bleeding episodes are related to the level of factor IX clotting activity. In individuals with severe hemophilia B, spontaneous joint or deep-muscle bleeding is the most frequent sign. Individuals with severe hemophilia B are usually diagnosed during the first two years of life; without prophylactic treatment, they may average up to two to five spontaneous bleeding episodes each month. Individuals with moderate hemophilia B seldom have spontaneous bleeding; however, they do have prolonged or delayed oozing after relatively minor trauma and are usually diagnosed before age five to six years; the frequency of bleeding episodes varies from once a month to once a year. Individuals with mild hemophilia B do not have spontaneous bleeding episodes; however, without pre- and postoperative treatment, abnormal bleeding occurs with surgery or tooth extractions; the frequency of bleeding may vary from once a year to once every ten years. Individuals with mild hemophilia B are often not diagnosed until later in life. In any individual with hemophilia B, bleeding episodes may be more frequent in childhood and adolescence than in adulthood. Approximately 30% of heterozygous females have factor IX clotting activity lower than 40% and are at risk for bleeding (even if the affected family member has mild hemophilia B), although symptoms are usually mild. After major trauma or invasive procedures, prolonged or excessive bleeding usually occurs, regardless of severity.</Attribute>
                <XRef ID="NBK1495" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301668</ID>
                <ID Source="BookShelf">NBK1495</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22274582</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="UKHCDO, 2013">
                <ID Source="PubMed">23157203</ID>
              </Citation>
              <XRef ID="98879" DB="Orphanet" />
              <XRef ID="C0008533" DB="MedGen" />
              <XRef ID="D002836" DB="MeSH" />
              <XRef ID="MONDO:0010604" DB="MONDO" />
              <XRef Type="MIM" ID="306900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1478304" SubmissionDate="2018-04-02" DateLastUpdated="2018-05-28" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="746066|MedGen:C2749016;C0008533" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000768547" DateUpdated="2018-05-28" DateCreated="2018-05-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">3029178</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2198809</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24375831</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8304338</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">4045960</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the F9 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Whole gene deletions of F9 have been reported in numerous individuals with hemophilia B (PMID: 24375831, 8304338, 3029178, 2198809, 4045960). Loss-of-function variants in F9 are known to be pathogenic (PMID: 20301668). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_138612918)_(138644235_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2749016" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0008533" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1478304" TraitType="Disease" MappingType="XRef" MappingValue="C0008533" MappingRef="MedGen">
        <MedGen CUI="C0008533" Name="Hereditary factor IX deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1478304" TraitType="Disease" MappingType="XRef" MappingValue="C2749016" MappingRef="MedGen">
        <MedGen CUI="C2749016" Name="Thrombophilia, X-linked, due to factor 9 defect" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

